Navigator Medicines announced it raised $50 Million in an initial filing from an offering of $100 Million
PRIVATESep 05, 2024
Amount Raised
$50 Million
Round Type
Venture
Scotch PlainsBiotechnologyHealth CareTherapeutics
Company Information
Company
Navigator Medicines
Location
Scotch Plains, New Jersey, United States
About
Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammatory diseases. The company is focused on innovation that enhances patient care.
Fundz sees it the moment Navigator Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.